179 related articles for article (PubMed ID: 9044877)
1. Potential use of iodine-123 metaiodobenzylguanidine radioaerosol as a marker of pulmonary neuroadrenergic function.
Giordano A; Calcagni ML; Rossi B; Fuso L; Accardo D; Valente S; Pistelli R; Franceschini R; Troncone L
Eur J Nucl Med; 1997 Jan; 24(1):52-8. PubMed ID: 9044877
[TBL] [Abstract][Full Text] [Related]
2. Use of metaiodobenzylguanidine (MIBG) in pneumology.
Giordano A; Calcagni ML; Rossi B; Rufini V; Fuso L; Valente S; Pistelli R; Franceschini R; Troncone L
Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):49-54. PubMed ID: 9002749
[TBL] [Abstract][Full Text] [Related]
3. Use of iodine-123 metaiodobenzylguanidine scintigraphy for the detection of amiodarone induced pulmonary toxicity in a rabbit model: a comparative study with technetium-99m diethyltriaminepenta acetic acid radioaerosol scintigraphy.
Durmuş-Altun G; Altun A; Aktas RG; Salihoglu YS; Yigitbasi NO
Ann Nucl Med; 2005 May; 19(3):217-24. PubMed ID: 15981675
[TBL] [Abstract][Full Text] [Related]
4. Potential of iodine-123 metaiodobenzylguanidine single-photon emission tomography to detect abnormal functional status of the pulmonary neuroadrenergic system in irradiated lung.
Suga K; Kume N; Shimizu K; Nishigauchi K; Hara A; Motoyama K; Matsunaga N
Eur J Nucl Med; 1999 Jun; 26(6):647-54. PubMed ID: 10369951
[TBL] [Abstract][Full Text] [Related]
5. Effect of inhaled surfactant on pulmonary deposition and clearance of technetium-99m-DTPA radioaerosol.
Suga K; Mitra A; Domingues C; Alderson PO
J Nucl Med; 1998 Mar; 39(3):543-7. PubMed ID: 9529308
[TBL] [Abstract][Full Text] [Related]
6. 123I-MIBG radioaerosol lung clearance in COPD patients with fixed and partially reversible obstruction to evaluate the functional status of pulmonary adrenergic innervation.
Antonelli Incalzi R; Giordano A; Fuso L; Basso S; Calcagni ML; Reale F; Boniello V; Pistelli R
Nucl Med Commun; 2002 Dec; 23(12):1217-20. PubMed ID: 12464788
[TBL] [Abstract][Full Text] [Related]
7. Detection of acute inhalation injury in fire victims by means of technetium-99m DTPA radioaerosol inhalation lung scintigraphy.
Lin WY; Kao CH; Wang SJ
Eur J Nucl Med; 1997 Feb; 24(2):125-9. PubMed ID: 9021108
[TBL] [Abstract][Full Text] [Related]
8. Metaiodobenzylguanidine as an index of atrioventricular nodal adrenergic activity.
Lurie KG; Dae MW; Dutton J; Velazquez-Rocha SJ; O'Connell JW
J Nucl Med; 1995 Jun; 36(6):1096-101. PubMed ID: 7769434
[TBL] [Abstract][Full Text] [Related]
9. Scintigraphic imaging with 123I-metaiodobenzylguanidine as a marker of cardiac adrenergic neurotransmission in the rat.
Gayheart-Walsten P; Snyder D; Mack J; Boland C; Roberts J
Methods Find Exp Clin Pharmacol; 1995 May; 17(4):249-54. PubMed ID: 7475511
[TBL] [Abstract][Full Text] [Related]
10. Ten years of experience with MIBG applications and the potential of new radiolabeled peptides: a personal overview and concluding remarks.
Shapiro B
Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):150-5. PubMed ID: 9002776
[TBL] [Abstract][Full Text] [Related]
11. Increased lung uptake of iodine-123-MIBG in diabetics with sympathetic nervous dysfunction.
Murashima S; Takeda K; Matsumura K; Yamakado K; Sakuma H; Kitano T; Nakagawa T; Ichihara T; Yamakado T; Murata K
J Nucl Med; 1998 Feb; 39(2):334-8. PubMed ID: 9476946
[TBL] [Abstract][Full Text] [Related]
12. [Myocardial imaging with 123I-metaiodobenzylguanidine (123I-MIBG) in essential hypertension: does the 123I-MIBG imaging have the ability to predict its prognosis?].
Narita M; Kurihara T; Murano K; Usami M; Honda M
Kaku Igaku; 1994 Aug; 31(8):879-89. PubMed ID: 7933677
[TBL] [Abstract][Full Text] [Related]
13. Abnormalities of cardiac sympathetic function in pacing-induced heart failure as assessed by [123I]metaiodobenzylguanidine scintigraphy.
Simmons WW; Freeman MR; Grima EA; Hsia TW; Armstrong PW
Circulation; 1994 Jun; 89(6):2843-51. PubMed ID: 8205700
[TBL] [Abstract][Full Text] [Related]
14. Skeletal assessment in neuroblastoma--the pitfalls of iodine-123-MIBG scans.
Gordon I; Peters AM; Gutman A; Morony S; Dicks-Mireaux C; Pritchard J
J Nucl Med; 1990 Feb; 31(2):129-34. PubMed ID: 2313350
[TBL] [Abstract][Full Text] [Related]
15. Assessment of alveolar epithelial permeability in Behçet's disease with 99mTc-DTPA aerosol scintigraphy.
Gumuser FG; Pirildar T; Batok D; Sakar A; Ruksen E; Sayit E
Ann Nucl Med; 2008 Jun; 22(5):349-55. PubMed ID: 18600411
[TBL] [Abstract][Full Text] [Related]
16. [The heterogeneity of myocardial sympathetic innervation in normal subjects: an assessment by iodine-123 metaiodobenzylguanidine scintigraphy].
D'Alto M; Maurea S; Basso A; Varrella P; Polverino W; Bianchi U; Bonelli A; Salvatore M; Chiariello M
Cardiologia; 1998 Nov; 43(11):1231-6. PubMed ID: 9922590
[TBL] [Abstract][Full Text] [Related]
17. Reduced myocardial 123I-metaiodobenzylguanidine uptake in newly diagnosed IDDM patients.
Schnell O; Muhr D; Weiss M; Dresel S; Haslbeck M; Standl E
Diabetes; 1996 Jun; 45(6):801-5. PubMed ID: 8635656
[TBL] [Abstract][Full Text] [Related]
18. Technetium 99m-diethylene triamine penta-acetic acid aerosol clearance in the evaluation of pulmonary involvement in sickle cell disease.
Onadeko BO; Marouf R; Omar AM; Hijazi Z; Khadadah M; Qurtom M; Collier BD; Elgazzar AH; Adekile AD
Eur J Haematol; 2006 Feb; 76(2):147-52. PubMed ID: 16405436
[TBL] [Abstract][Full Text] [Related]
19. Cardiac iodine-123 metaiodobenzylguanidine uptake in animals with diabetes mellitus and/or hypertension.
Dubois EA; Kam KL; Somsen GA; Boer GJ; de Bruin K; Batink HD; Pfaffendorf M; van Royen EA; van Zwieten PA
Eur J Nucl Med; 1996 Aug; 23(8):901-8. PubMed ID: 8753678
[TBL] [Abstract][Full Text] [Related]
20. Relation of iodine-123 metaiodobenzylguanidine myocardial scintigraphy to endomyocardial biopsy findings in patients with dilated cardiomyopathy.
Murata K; Kusachi S; Murakami T; Nogami K; Murakami M; Hirohata S; Tominaga Y; Komatsubara I; Tsuji T
Clin Cardiol; 1997 Jan; 20(1):61-6. PubMed ID: 8994740
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
